ACRSAclaris Therapeutics, Inc.

$407M

FY 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4M-58.1% YoY

Gross Profit

$172,0004.1% margin

Operating Income

-$111M-2627.3% margin

Net Income

-$161M-3817.2% margin

EPS (Diluted)

$-3.46

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$98M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$98M

Total Liabilities

$28M

Stockholders' Equity

$70M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$10M	-58.1%
Gross Profit	$172,000	$3M	-94.7%
Operating Income	-$111M	-$135M	+18.0%
Net Income	-$161M	-$133M	-21.6%

ACRS FY 2019 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena